These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 11097467

  • 1. Relationships between the copper and iron systems in hemodialysis patients and variables affecting these systems.
    Kirschbaum B.
    Biol Trace Elem Res; 2000 Oct; 77(1):13-24. PubMed ID: 11097467
    [Abstract] [Full Text] [Related]

  • 2. Primary plasma antioxidants in adult respiratory distress syndrome patients: changes in iron-oxidizing, iron-binding, and free radical-scavenging proteins.
    Gutteridge JM, Quinlan GJ, Mumby S, Heath A, Evans TW.
    J Lab Clin Med; 1994 Aug; 124(2):263-73. PubMed ID: 8051491
    [Abstract] [Full Text] [Related]

  • 3. The effect of a low-protein diet on serum levels of ceruloplasmin and transferrin in patients with chronic renal failure.
    Marecek Z, Vulterinová M, Skála I, Pechar J, Doberský P, Schück O, Nádvorníková H, Heyrovský I.
    Clin Nephrol; 1978 Jan; 9(1):38-40. PubMed ID: 630743
    [Abstract] [Full Text] [Related]

  • 4. Changes in serum ferritin and other factors associated with iron metabolism during chronic hyperbaric exposure.
    Gilman SC, Hunter WL, Mooney LW.
    Aviat Space Environ Med; 1979 Mar; 50(3):223-6. PubMed ID: 454320
    [Abstract] [Full Text] [Related]

  • 5. Impact of diabetes mellitus on the relationships between iron-, inflammatory- and oxidative stress status.
    Van Campenhout A, Van Campenhout C, Lagrou AR, Abrams P, Moorkens G, Van Gaal L, Manuel-y-Keenoy B.
    Diabetes Metab Res Rev; 2006 Mar; 22(6):444-54. PubMed ID: 16506275
    [Abstract] [Full Text] [Related]

  • 6. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients.
    Panichi V, Taccola D, Rizza GM, Consani C, Migliori M, Filippi C, Paoletti S, Sidoti A, Borracelli D, Panicucci E, Giovannini L.
    J Nephrol; 2004 Mar; 17(5):715-20. PubMed ID: 15593040
    [Abstract] [Full Text] [Related]

  • 7. Changes of serum iron transferrin and copper ceruloplasmin in rats given Cu(II)2 (acetylsalicylate)4 during acute inflammation.
    Ferrari RP, Paradisi L, Torrielli M.
    Anticancer Res; 1989 Mar; 9(3):771-3. PubMed ID: 2548436
    [Abstract] [Full Text] [Related]

  • 8. Serum antioxidant activity in diabetes mellitus.
    Jones AF, Winkles JW, Jennings PE, Florkowski CM, Lunec J, Barnett AH.
    Diabetes Res; 1988 Feb; 7(2):89-92. PubMed ID: 3396268
    [Abstract] [Full Text] [Related]

  • 9. Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease.
    Aigner E, Theurl I, Haufe H, Seifert M, Hohla F, Scharinger L, Stickel F, Mourlane F, Weiss G, Datz C.
    Gastroenterology; 2008 Aug; 135(2):680-8. PubMed ID: 18505688
    [Abstract] [Full Text] [Related]

  • 10. Alteration in iron metabolism during retinal degeneration in rd10 mouse.
    Deleon E, Lederman M, Berenstein E, Meir T, Chevion M, Chowers I.
    Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1360-5. PubMed ID: 18997094
    [Abstract] [Full Text] [Related]

  • 11. Stimulation of the ferroxidase activity of ceruloplasmin during iron loading into ferritin.
    Reilly CA, Aust SD.
    Arch Biochem Biophys; 1997 Nov 15; 347(2):242-8. PubMed ID: 9367531
    [Abstract] [Full Text] [Related]

  • 12. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N, Osman-Malik Y, Frinak S, Besarab A.
    Am J Kidney Dis; 2006 Apr 15; 47(4):644-54. PubMed ID: 16564942
    [Abstract] [Full Text] [Related]

  • 13. Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin--the antioxidant proteins.
    Chauhan A, Chauhan V, Brown WT, Cohen I.
    Life Sci; 2004 Oct 08; 75(21):2539-49. PubMed ID: 15363659
    [Abstract] [Full Text] [Related]

  • 14. Effect of intravenous iron administration frequency on AOPP and inflammatory biomarkers in chronic hemodialysis patients: a pilot study.
    Anraku M, Kitamura K, Shintomo R, Takeuchi K, Ikeda H, Nagano J, Ko T, Mera K, Tomita K, Otagiri M.
    Clin Biochem; 2008 Oct 08; 41(14-15):1168-74. PubMed ID: 18692036
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Lens epithelial cells synthesize and secrete ceruloplasmin: effects of ceruloplasmin and transferrin on iron efflux and intracellular iron dynamics.
    Harned J, Fleisher LN, McGahan MC.
    Exp Eye Res; 2006 Oct 08; 83(4):721-7. PubMed ID: 16806171
    [Abstract] [Full Text] [Related]

  • 17. Reticulocyte hemoglobin content in hemodialysis patients with acute infection.
    Mitsuiki K, Harada A, Miyata Y.
    Clin Exp Nephrol; 2004 Sep 08; 8(3):257-62. PubMed ID: 15480904
    [Abstract] [Full Text] [Related]

  • 18. [Serum levels of iron, copper, transferrin and ceruloplasmin oxidative activity in chronic circulatory failure].
    Bielak J.
    Pol Tyg Lek; 1971 Oct 08; 26(43):1654-7. PubMed ID: 5133680
    [No Abstract] [Full Text] [Related]

  • 19. Zinc and copper concentration in plasma and erythrocytes of patients with chronic renal failure.
    Paniagua-Sierra JR, Pérez-López A, Diaz-Bensussen S, Solís-Alpuche L, Saavedra-Guatemala H, Exaire-Murad JE.
    Arch Invest Med (Mex); 1981 Oct 08; 12(1):69-82. PubMed ID: 7247613
    [Abstract] [Full Text] [Related]

  • 20. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.
    El-Khatib M, Duncan HJ, Kant KS.
    Nephrology (Carlton); 2006 Oct 08; 11(5):400-4. PubMed ID: 17014552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.